Similar articles

• [The changes of natural clotting and fibrinolytic inhibitors in collagen and collagen like diseases (author's transl)].

  Oguri T, Hosoi A. Oguri T, et al. Rinsho Ketsueki. 1978 Jul;19(7):940-6. Rinsho Ketsueki. 1978. PMID: 81329 Japanese. No abstract available.
• Alpha 2-macroglobulin and antithrombin-heparin cofactor: modulators of hemostatic and inflammatory reactions. Alpha 2-macroglobulin.

  Harpel PC, Rosenberg RD. Harpel PC, et al. Prog Hemost Thromb. 1976;3:145-89. Prog Hemost Thromb. 1976. PMID: 59937 Review. No abstract available.
• [Changes of antithrombin III, alpha2-macroglobulin, alpha1-antitrypsin, C1-inhibitor and alpha2-plasmin inhibitor in arteriosclerotic diseases and diabetes mellitus (author's transl)].

  Matsuda T. Matsuda T. Rinsho Ketsueki. 1978 Jul;19(7):947-54. Rinsho Ketsueki. 1978. PMID: 81330 Japanese. No abstract available.
• Changes in protease inhibitors after acute myocardial infarction.

  Rennie JA, Crawford GP, Ogston D. Rennie JA, et al. J Clin Pathol. 1976 Jul;29(7):639-41. doi: 10.1136/jcp.29.7.639. J Clin Pathol. 1976. PMID: 61974 Free PMC article.
• Plasma coagulation proteases, proteolytic inhibitors, and their interaction with platelets.

  Rao AK, Schmaier AH, Colman RW. Rao AK, et al. Pathobiol Annu. 1982;12:35-64. Pathobiol Annu. 1982. PMID: 6186978 Review. No abstract available.